Dr. Maria L. Cannarozzi, MD

Dr. Cannarozzi practices at New West Physicians Inc in Lone Tree, Colorado.

Dr. Cannarozzi's NPI, 1316956105, was assigned on August 8, 2006. Dr. Cannarozzi graduated from USF Health Morsani College of Medicine in 2000. Dr. Cannarozzi holds Colorado license DR.0064672.

Dr. Cannarozzi's primary practice is New West Physicians Inc, at 9695 S Yosemite St, Lone Tree, CO 80124 in Douglas County. The practice phone is (303) 763-4900.

Dr. Cannarozzi's primary practice is New West Physicians Inc in Lone Tree, Colorado. The medical group on file is Optumcare Colorado Medical Group. Dmand AI also links Dr. Cannarozzi to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cannarozzi practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Cannarozzi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Cannarozzi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Cannarozzi's licenses on file in 2 states: Colorado and Florida.

Dmand AI lists acid reflux, arthritis, asthma, atrial fibrillation and flutter, chronic diabetes, chronic hypertension, coronary artery disease and diabetic emergency among the conditions Dr. Cannarozzi treats.

CMS data shows 132 Medicare services from Dr. Cannarozzi across 5 procedure codes in 2024, for 69 Medicare patients. Medicare paid $11,189 for them. Every service was in an office.

CMS counts 69 Medicare patients who saw Dr. Cannarozzi in 2024. 52% of them have high cholesterol, and 45% have high blood pressure. Their average risk score is 0.65, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cannarozzi's median patient age at 70, with 73% women.

In 2024, Dr. Cannarozzi wrote 8,914 Medicare Part D claims for 1,081 patients. 86% of them were for generic drugs. CMS names the drug for 8,177 of them, across 140 drugs with 11 or more claims each, at $480,244 in total drug cost. In 2023, CMS named 5,380 claims across 108 drugs.

Dr. Cannarozzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cannarozzi as offering telehealth.

Dmand AI links 7 papers to Dr. Cannarozzi, published from 2013 to 2017. 2013 was the busiest year, with 2. The most frequent topics are Clinical Competence, Clinical Clerkship and Curriculum. Dr. Cannarozzi has published most often in Teach Learn Med. Dr. Cannarozzi's most frequent co-authors are Meenakshy Aiyer, MD, Stephen Berman, MD and Heather E. Harrell, MD.

CMS Open Payments shows 2 general payments to Dr. Cannarozzi from 2 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $42.

Dr. Cannarozzi graduated from USF Health Morsani College of Medicine in 2000.

Dr. Cannarozzi is in network with 13 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.